Sinocelltech Group Limited Class ASSE: 688520

Announcement on Voluntary Disclosure of Obtaining Notice of Approval of Drug Clinical Trial for Holding Subsidiary's Product SCTB39-1

· Issued by Sinocelltech Group Limited Class A via Shanghai Stock Exchange
Announcement on Voluntary Disclosure of Obtaining Notice of Approval of Drug Clinical Trial for Holding Subsidiary's Product SCTB39-1

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis